Atlas.
Sign inStart free trial
ARVNNASDAQ · US

ARVINAS, INC.

Technology · Pharmaceutical Preparations

TechnologyPharmaceutical Preparations
CEO
Randy Teel
Founded
—
IPO Date
—
HQ
New Haven, CT, United States
Exchange
NASDAQ
Employees
n.a.

Share Price Performance

$8.20 ▼ 28.5%
Last (1 Jul 2026) · $8
Period High · $13.83
Period Low · $0.00
52W: $8.20 – $13.83

Key Metrics

Share Price
$8.20
-1.3% today
Market Cap
$527M
P / E
—
EV / Revenue
1.5x
Revenue Growth
-0.3%
year-on-year
Gross Margin
—
Enterprise Value
$385M
52W High
$13.83
52W Low
$0.00
Avg Volume
853K
daily

Sources: SEC filings · Market data as of Jul 6, 2026

Shareholders' Structure
12 known institutional holders·$136M total on record·2026-Q1
BlackRock, Inc.
10.6%·$72M
State Street Corp
2.8%·$19M
Geode Capital Management, LLC
2.4%·$17M
Goldman Sachs Group Inc
1.2%·$8M
Northern Trust Corp
0.8%·$6M
Dimensional Fund Advisors LP
0.8%·$5M
Price T Rowe Associates Inc
0.7%·$4,528
Invesco Ltd.
0.5%·$3M
Point72 Asset Management, L.P.
0.4%·$2M
Jpmorgan Chase & Co
0.2%·$1M
Bank Of America Corp
0.2%·$1M
Fmr LLC
0.1%·$935,259
Free Float
79.3%

Sources: SEC filings

Notes: % shown as share of total shares outstanding · Free float = shares outstanding minus all known 13F institutional holdings

What Atlas covers for ARVINAS, INC.
OverviewARVINAS, INC. share price history (10 years), key market statistics, and institutional shareholder structure from SEC 13F-HR filings.Business ModelHow ARVINAS, INC. generates revenue — product and service segments, geographic breakdown, key operating metrics, and 10-year business evolution sourced from SEC filings.FinancialsARVINAS, INC.'s complete financial history — 10 years of annual revenue, gross margins, operating income, net income, EPS, and free cash flow from SEC filings, plus 12 quarters of quarterly results.Management QualityARVINAS, INC. executive team profiles, insider buying and selling from SEC Form 4, earnings call transcripts, and a track record of guidance delivery vs actual results.Risk FactorsARVINAS, INC.'s annual risk disclosures from SEC filings — full text, 5-year evolution showing how risks have shifted, and year-on-year delta highlighting new and removed risks.NewsAI-synthesised news digest for ARVINAS, INC., updated regularly with key developments, earnings updates, product announcements, and material company events.SentimentInvestor sentiment for ARVINAS, INC. aggregated from X.com, Reddit, and Hacker News — discussion themes, Bull and Bear signals, and community analysis.Valuation & PeersARVINAS, INC. valuation multiples — P/E, EV/Revenue, EV/EBITDA — compared against a curated set of industry peers using live data from SEC filings. Custom peer selection available.DCF BuilderBuild a discounted cash flow model for ARVINAS, INC. with 10 years of pre-filled revenue, margins, and cash flow data from SEC filings. Adjust growth rates, WACC, and terminal assumptions.Atlas AnalysisAtlas AI research synthesis for ARVINAS, INC. — business model, financial health, management quality, risk profile, and institutional ownership, grounded exclusively in SEC filings.

Unlock the full analysis

9-tab institutional research sourced directly from SEC filings. No tips, no scores — the same process professional investors use.

7-day free trial · Plus & Pro · No charge during trial